Antisense Therapeutics Price Target Cut 17% to A$0.30/Share by Wilsons
Antisense Therapeutics Price Target Cut 17% to A$0.30/Share by Wilsons
威爾遜將Antisense Therapeutics的目標股價下調17%,至每股0.30澳元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊